INNATE PHARMA: cash_and_equivalents
| Value | {"amount": 84225000.0, "concept": "ifrs-full:CashAndCashEquivalents"} |
|---|---|
| Period | (as of 2022-12-31) |
| Status | current |
| Entity | INNATE PHARMA |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T23:19:24.905918+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/9fbe132c-c78a-4ec4-a088-7089f45ff71c
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:9695002Y8420ZB8HJE29:2024-12-31Retrieved: 2026-08-23T23:19:24.905918+02:00
Raw response sha256:
c477e47ed4a27d7e67bbe48f2d843a4d…Cite as: FACTANKER, https://factanker.com/fact/9fbe132c-c78a-4ec4-a088-7089f45ff71c
History
- no predecessors — first report